Primary and Secondary Stroke Prevention with Antiplatelet Drugs

E-ISSN： 1873-4286|12|10|1293-1297

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.10, 2006-04, pp. : 1293-1297

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiplatelet therapy in secondary stroke prevention

By Crawford K Michelle Talbert Robert L

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 10, 2001-10 ,pp. : 1609-1613

Informa Healthcare

Access to resources Recommend Favorite

Strategies for the primary and secondary prevention of stroke

Inpharma, Vol. 1, Iss. 1357, 2002-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Aspirin and Antiplatelet Agent Resistance: Implications for Prevention of Secondary Stroke

By Greer David M.

CNS Drugs, Vol. 24, Iss. 12, 2010-12 ,pp. : 1027-1040

Adis International

Access to resources Recommend Favorite

Clinical Pharmacokinetics of Antiplatelet Agents Used in the Secondary Prevention of Stroke

By Lenz T.L. Wilson A.F.

Clinical Pharmacokinetics, Vol. 42, Iss. 10, 2003-01 ,pp. : 909-920

Adis International

Access to resources Recommend Favorite

Stroke Prevention: From Available Antiplatelet Drugs to Novel Molecular Targets

Current Drug Targets, Vol. 14, Iss. 1, 2013-01 ,pp. : 3-12

Bentham Science Publishers

Access to resources Recommend Favorite